Gene Query: MAML3

Dataset Description Geneva Score
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 52.4
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 52.4
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 27.37
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 19.89
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 19.89
RNA expression analysis upon JMJD1C depletion 19.37
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 19.37
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 18.81
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 17.9
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 17.84
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 14.87
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 14.71
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 14.7
RNA sequencing analysis of human embryonic stem cells and axial progenitors 14.41
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 13.89
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 13.79
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 13.44
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 13.34
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 13.34
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 13.23
TGF-β promotes genomic instability after loss of RUNX3 13.17
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 13.11
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 13.11
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 13.09
CHCHD2 gene KO effect in iPSC drived motor neurons 13.06
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 12.64
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 12.41
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 12.34
Recovery and analysis of nascent RNA 12.34
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 12.31
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 11.44
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 11.19
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 10.24
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 10.2
Transcriptome analysis of BAP1 knockout and restoration 10.2
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 10.17
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 10.1
Transcriptional profiles of normal human mature B cells 10.07
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 9.99
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 9.9
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 9.88
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 9.86
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 9.82
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 9.77
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 9.77
An integrative analysis of non-coding regulatory DNA variations associated with autism 9.76
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 9.69
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 9.57
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 9.44
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 9.37
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 9.36
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 9.25
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 9.25
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 9.0
Nutritional control of protein translation 8.97
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 8.87
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 8.87
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 8.72
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 8.64
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 8.64
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 8.64
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 8.41
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 8.35
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 8.27
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 8.23
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 8.13
Role of COP1 on MAP kinase transcriptional output in melanoma 7.99
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 7.94
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 7.91
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 7.76
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 7.66
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 7.46
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 7.46
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 7.46
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 7.43
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 7.38
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 7.37
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 7.34
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 7.25
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 7.25
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 7.17
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 7.14
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 7.14
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 7.13
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 7.13
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 7.12
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 7.04
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 6.86
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 6.83
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 6.83
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 6.69
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 6.67
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 6.64
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 6.64
LNCaP treated with iBET 6.62
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 6.51
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 6.49
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 6.47
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 6.46
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 6.42
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 6.41
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 6.33
Studying the selectivity of a small molecule Synucleozid on transcriptome 6.3
Selective suppression of endothelial cytokine production by progesterone receptor 6.28
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 6.28
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 6.23
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 6.23
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 6.22
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 6.22
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 6.19
Nonpregnant and term pregnant human myometrial tissues 6.19
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 6.14
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 6.06
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 6.06
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 5.97
RNA-Seq from early time points in the kidney differentiation protocol 5.9
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 5.9
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 5.89
The pause-initiation limit restricts transcription activation in human cells 5.84
FGF2 regulation of gene expression in stable inducible Neurons 5.76
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 5.67
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 5.65
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 5.64
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 5.58
A549 cells and MSR-A549 cells 5.55
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 5.55
Leucegene: ALL sequencing 5.53
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 5.43
Depicting early human development and germ cell origin with porcine embryos 5.43
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 5.38
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 5.38
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 5.35
HNRNPL and its RNA Targets in Prostate Cancer 5.35
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.35
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 5.34
Transcriptional effect of ETV1 knockdown in melanoma cells 5.34
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.33
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 5.32
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 5.32
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 5.21
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 5.21
TAF1 is critical for AE driven leukemogenesis 5.21
CHCHD10 gene KO effect in iPSC drived motor neurons 5.17
RNA-Seq with and without RNase treatment in PCa cell lines 5.17
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 5.15
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 5.13
PGE2 mediated gene expression changes in human cervical stromal cells 5.11
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 5.05
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 5.01
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 4.99
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 4.95
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 4.88
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 4.86
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 4.86
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 4.86
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 4.86
Hepatosplenic T cell lymphoma 4.86
miRNAs affected by antagomiR-17 treatment 4.84
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 4.82
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 4.82
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 4.81
Interphase condensins regulate ligand-depedent enhancer activation 4.81
EP400 is required for Max and MCPyV mediated gene activation 4.8
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 4.76
Identification of transcription start sites for human A549 cell line using ReCappable-seq 4.73
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 4.72
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 4.71
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 4.71
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 4.67
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 4.67
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 4.67
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 4.64
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 4.62
HNF1A deficiency impairs β-cell fate, granule maturation and function 4.6
Investigation about fibroblasts of different origins in culture 4.6
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 4.58
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 4.58
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 4.57
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 4.57
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 4.55
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 4.55
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 4.52
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 4.52
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 4.51
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 4.42
Identification of Nrf2 regulated genes by RNA sequencing 4.38
Nrf2 regulated genes in A549 cells 4.38
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 4.35
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 4.35
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 4.35
Intron retention induced by microsatellite expansions as a disease biomarker. 4.32
Transcriptomic profile of human embryonic renal corpuscles 4.28
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 4.25
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 4.25
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 4.24
CircRNAome diversity in human mature B-cells, T-cells and monocytes 4.22
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.21
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 4.2
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 4.15
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 4.1
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 4.09
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 4.07
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 4.06
Differentiation enhances Zika virus infection in neuronal brain cells 4.05
Tpl-2 and MEK small molecule inhibitors 4.05
Tpl-2 small molecule project 4.05
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 4.04
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 4.03
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 4.03
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 4.01
Widespread intronic polyadenylation diversifies immune cell transcriptomes 3.98
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 3.98
Dysregulated immune system networks in war veterans with PTSD 3.96
A map of gene expression in neutrophil-like cell lines 3.95
Dtx3L and Androgen Signaling in Prostate Cancer 3.95
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 3.95
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 3.95
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 3.92
DIGIT regulates endoderm differentiation of human embryonic stem cells 3.89
Differentially expressed vascular development genes for iPSC-ECs from CDI 3.89
RNA-seq analysis of uveal melanoma cells treated with FR900359 3.89
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 3.88
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 3.83
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 3.82
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 3.81
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 3.78
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 3.74
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.73
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 3.64
Statins modulate endothelial transcriptional profile by inhibiting EZH2 3.63
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 3.61
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 3.61
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 3.61
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 3.6
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 3.6
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 3.59
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 3.59
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 3.58
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 3.58
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 3.57
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 3.56
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 3.52
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 3.51
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.5
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.5
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 3.5
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 3.49
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 3.49
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 3.48
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 3.48
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.47
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 3.46
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.45
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.45
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.41
Overexpression and knockdown experiment for circCSNK1G3 3.4
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 3.35
HEXIM1 is induced by DHODH inhibition to suppress melanoma 3.33
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 3.33
Targeting MTHFD2 in Acute Myeloid Leukemia 3.33
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 3.31
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 3.31
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 3.29
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 3.26
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 3.24
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 3.23
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 3.23
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 3.17
Exploring ILF2 regulatory genes by next-generation sequencing 3.16
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 3.15
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.14
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 3.14
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 3.11
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 3.1
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 3.08
Engineering Patient-Specific Tissue Implants 3.06
LINE-2 transposable elements are a source of functional human microRNAs and target sites 3.04
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.04
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 3.03
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 3.02
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 3.02
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 3.0
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 2.98
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 2.97
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 2.97
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 2.97
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 2.93
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 2.91
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.9
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 2.88
RNA-seq of naive and primed ES cells (NHSM) 2.86
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.85
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 2.78
Dynamic 3D chromosomal landscapes in acute leukemia 2.77
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.77
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 2.73
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 2.72
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 2.71
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 2.7
RNA-Seq in neutrophils from Antiphospholipid Syndrome 2.7
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 2.67
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 2.66
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 2.64
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 2.64
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 2.64
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 2.64
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.62
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.6
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 2.58
Global gene expression profile of dasatinib-resistant RCH-ACV cells 2.54
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.53
RNA-sequencing of formalin fixed human primary melanoma tissue 2.5
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 2.5
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 2.5
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.49
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 2.47
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.44
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 2.44
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.38
Effects of rFVIIIFc on human macrophages 2.35
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 2.35
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.35
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 2.34
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 2.3
m6A-dependent regulation of messenger RNA stability 2.29
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 2.21
RNA sequencing of matched nephrectomy samples [RNA-seq] 2.21
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 2.21
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 2.18
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 2.18
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 2.16
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 2.11
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 2.11
RNA-sequencing in irradiated and normal A549 cells. 2.11
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 2.08
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.08
Clinker: visualizing fusion genes detected in RNA-seq data 2.07
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 2.04
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.03
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 2.03
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 2.01
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 2.01
Transcription control by the ENL YEATS domain in acute leukemia 2.0
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 2.0
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 2.0
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.0
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.97
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.92
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.91
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 1.89
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 1.89
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.88
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.87
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.82
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.82
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 1.8
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 1.78
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 1.78
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 1.73
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 1.67
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.66
A novel target of EZH1/2 for treatment of mantle cell lymphoma 1.63
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 1.56
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 1.55
Transcriptome of Stabilin-1 siRNA transfected human monocytes 1.55
The effect of Abl kinases on non-small cell carcinoma global transcriptome 1.52
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 1.5
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 1.49
BI Human Reference Epigenome Mapping Project 1.49
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.47
SF3B1 Degron knockdown RNA-seq 1.45
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 1.45
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 1.43
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 1.42
Changes in human endometrial gland transcriptome over the window of implantation 1.41
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.4
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.38
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.38
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 1.36
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.34
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 1.34
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 1.34
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.34
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 1.33
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 1.29
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 1.27
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 1.26
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.24
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.23
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 1.2
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.19
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.19
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 1.16
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.16
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.15
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 1.12
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 1.12
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 1.09
Dynamic reorganization of nuclear architecture during human cardiogenesis 1.09
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 1.06
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.03
Gene expression regulated by CSA and CSB in neuroblastoma cell line 1.01
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.97
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 0.96
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.92
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.92
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.91
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.9
Gene expression profiling in metabolically heterogeneous human lung tumors 0.9
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.89
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.89
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 0.88
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.84
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.84
Identification of long noncoding RNAs in T-ALL cell lines 0.83
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.8
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.78
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.77
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.77
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 0.76
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.76
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.76
Bone marrow derived human B cells [normal proB] 0.75
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.72
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.72
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.72
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.72
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.71
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.71
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.71
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 0.69
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.69
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.68
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.67
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 0.66
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.65
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.65
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.64
Identification of global XBP1s target gene expression in human prostate cancer cells 0.63
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.62
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.62
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.61
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.61
RNA-seq of SCLC PDX models treated with EP 0.53
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.5
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.49
Loss of endometrial plasticity in recurrent pregnancy loss 0.47
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 0.47
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.46
Disruption of GRIN2B impairs differentiation in human neurons 0.45
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.45
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.45
Transcriptome-wide response to synthetic chromatin protein PcTF 0.45
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.43
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.43
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.42
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.4
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.39
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.39
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.37
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.37
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 0.36
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.33
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 0.33
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.31
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.31
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.31
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.3
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.3
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.29
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.29
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.27
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.27
Leucegene: AML sequencing (part 6) 0.27
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.23
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.23
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.23
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.2
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.2
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.2
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.18
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.18
hNSCs siRNA NOVA2 0.17
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.15
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.15
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.15
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.12
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 0.09
Noncoding regions are the main source of targetable tumor-specific antigens 0.08
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.06
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.06
The role of CFTR in islet function 0.04
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.04
Transcriptome analysis of CNS leukemia 0.04
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 0.03
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.02
CD73 knockdown effect in pancreatic cancer cell lines 0.02
Gene expression alterations of pancreatic intraepithlial neoplasia 0.01
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.0
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation